 |
 |
|
|
Resources for Food and Drug Administration (FDA)Resources > FDA > ArticlesSub-Categories: Listings 981 - 990 of 2187:
FDA Panel to Review Abbott Data
The Food and Drug Administration said Tuesday it will ask an outside panel of medical experts whether clinical trial data submitted by Abbott Laborato...
FDA panel to review Tamiflu's effect on brain
A Food and Drug Administration panel on Tuesday will review reports of abnormal behavior and other brain effects in more than 1,800 children who had t...
FDA Panel to Review Theravance Drug
Theravance said Thursday after market close that a U.S. Food and Drug Administration panel will meet to review its new-drug application for skin-infec...
FDA Panel to Review Thoratec Device
Government health advisers will consider Friday whether a mechanical heart pump from Thoratec Corp. should be approved, despite missing a key effectiv...
FDA Panel To Review Two Proposed Diabetes Drugs
A U.S. Food and Drug Administration panel will review two proposed drugs to treat Type 2 diabetes next month.According to a meeting notice posted on t...
FDA Panel to Scrutinize Safety of Some Asthma Treatments
A Food and Drug Administration panel is going to hold hearings this week to review the safety of a particular group of asthma medications after the ag...
FDA panel to vote on new version of Genzyme drug
The Food and Drug Administration will ask a panel of experts next week whether studies by biotech firm Genzyme Corp. support approval of a new version...
FDA panel unanimously backs Lilly blood thinner
A panel of government health experts said Tuesday a highly anticipated Eli Lilly blood thinner marks a significant advance over older treatments and s...
FDA Panel Urges Clearer LASIK Warnings
A U.S. Food and Drug Administration panel says the agency should require enhanced warnings about the risks associated with LASIK eye surgery, an incr...
FDA Panel Urges Darvon Ban
The Darvon debate continues, but U.S. Food and Drug Administration (FDA) advisors are recommending the painkiller be pulled from the market. USA Tod... |
|
RSS Feeds|
Privacy Policy | Terms & Conditions | Support | Directory Links | Contact Us | Site Map | Home Copyright © 2007-2012 ComplianceHome.com. A SUPREMUS GROUP venture. All rights reserved. |
 |
 |